These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 8700544

  • 1. Variation in the sequence of Epstein Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphomas.
    Bhatia K, Raj A, Guitierrez MI, Judde JG, Spangler G, Venkatesh H, Magrath IT.
    Oncogene; 1996 Jul 04; 13(1):177-81. PubMed ID: 8700544
    [Abstract] [Full Text] [Related]

  • 2. Epstein-Barr virus-associated nuclear antigen-1 carboxy-terminal gene sequences in Japanese and American patients with gastric carcinoma.
    Chen YY, Chang KL, Chen WG, Shibata D, Hayashi K, Weiss LM.
    Lab Invest; 1998 Jul 04; 78(7):877-82. PubMed ID: 9690565
    [Abstract] [Full Text] [Related]

  • 3. EBNA-1 sequence variation in Danish and Chinese EBV-associated tumours: evidence for geographical polymorphism but not for tumour-specific subtype restriction.
    Sandvej K, Zhou XG, Hamilton-Dutoit S.
    J Pathol; 2000 Jun 04; 191(2):127-31. PubMed ID: 10861570
    [Abstract] [Full Text] [Related]

  • 4. Characterization of Epstein-Barr virus genotype in AIDS-related non-Hodgkin's lymphoma.
    Fassone L, Cingolani A, Martini M, Migliaretti G, Oreste PL, Capello D, Gloghini A, Vivenza D, Dolcetti R, Carbone A, Antinori A, Gaidano G, Larocca LM.
    AIDS Res Hum Retroviruses; 2002 Jan 01; 18(1):19-26. PubMed ID: 11804553
    [Abstract] [Full Text] [Related]

  • 5. Sequence variations in EBNA-1 may dictate restriction of tissue distribution of Epstein-Barr virus in normal and tumour cells.
    Gutiérrez MI, Raj A, Spangler G, Sharma A, Hussain A, Judde JG, Tsao SW, Yuen PW, Joab I, Magrath IT, Bhatia K.
    J Gen Virol; 1997 Jul 01; 78 ( Pt 7)():1663-70. PubMed ID: 9225043
    [Abstract] [Full Text] [Related]

  • 6. Analysis of Epstein-Barr virus (EBV) nuclear antigen 1 subtypes in EBV-associated lymphomas from Brazil and the United Kingdom.
    MacKenzie J, Gray D, Pinto-Paes R, Barrezueta LFM, Armstrong AA, Alexander FA, McGeoch DJ, Jarrett RF.
    J Gen Virol; 1999 Oct 01; 80 ( Pt 10)():2741-2745. PubMed ID: 10573169
    [Abstract] [Full Text] [Related]

  • 7. EBNA-1 sequence variations reflect active EBV replication and disease status or quiescent latency in lymphocytes.
    Wang JT, Sheeng TS, Su IJ, Chen JY, Chen MR.
    J Med Virol; 2003 Mar 01; 69(3):417-25. PubMed ID: 12526054
    [Abstract] [Full Text] [Related]

  • 8. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT, Fernandes BJ, Mock D.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug 01; 92(2):184-93. PubMed ID: 11505266
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas.
    Young LS, Yao QY, Rooney CM, Sculley TB, Moss DJ, Rupani H, Laux G, Bornkamm GW, Rickinson AB.
    J Gen Virol; 1987 Nov 01; 68 ( Pt 11)():2853-62. PubMed ID: 2824665
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virus.
    Aitken C, Sengupta SK, Aedes C, Moss DJ, Sculley TB.
    J Gen Virol; 1994 Jan 01; 75 ( Pt 1)():95-100. PubMed ID: 8113744
    [Abstract] [Full Text] [Related]

  • 13. The LCR of EBV makes Burkitt's lymphoma endemic.
    Niller HH, Salamon D, Banati F, Schwarzmann F, Wolf H, Minarovits J.
    Trends Microbiol; 2004 Nov 01; 12(11):495-9. PubMed ID: 15488390
    [Abstract] [Full Text] [Related]

  • 14. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
    Van Scoy S, Watakabe I, Krainer AR, Hearing J.
    Virology; 2000 Sep 15; 275(1):145-57. PubMed ID: 11017796
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Epstein-Barr Virus EBNA-2 gene expression enhances lymphotoxin production by B lymphocytes.
    McClain K, Estrov Z, Raju U, Kelley PK, Aggarwal BB.
    Methods; 1997 Jan 15; 11(1):83-7. PubMed ID: 8990093
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Alternative splicing determines the carboxy terminus of the Epstein-Barr virus nuclear antigen 5 species expressed in the Burkitt's lymphoma cell line Daudi.
    Ring CJ, Jones MD, Griffin BE.
    J Gen Virol; 1992 Oct 15; 73 ( Pt 10)():2715-9. PubMed ID: 1328484
    [Abstract] [Full Text] [Related]

  • 20. P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus.
    Wang Y, Finan JE, Middeldorp JM, Hayward SD.
    Virology; 1997 Sep 15; 236(1):18-29. PubMed ID: 9299613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.